Kidney disease trials for the 21st century: innovations in design and conduct
Compared to other specialties, nephrology has reported relatively few clinical trials, and most of these are too small to detect moderate treatment effects. Consequently, interventions that are commonly used by nephrologists have not been adequately tested and some may be ineffective or harmful. Mor...
Hoofdauteurs: | Herrington, W, Staplin, N, Haynes, R |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
Nature Research
2019
|
Gelijkaardige items
-
Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease
door: Zhu, D, et al.
Gepubliceerd in: (2025) -
Empagliflozin and cardiovascular outcomes in patients with chronic kidney disease: the EMPA-KIDNEY trial
door: Preiss, D, et al.
Gepubliceerd in: (2022) -
Diabetic kidney disease – stumbling blocks, discoveries and opportunities in the 21st century
door: Thiam, Christopher Seong Lim
Gepubliceerd in: (2022) -
Spaces of innovation : 21st century technopoles
door: Seitinger, Susanne, 1978-
Gepubliceerd in: (2005) -
Organization modeling : innovative architectures for the 21st century /
door: 343317 Morabito, Joseph, et al.
Gepubliceerd in: (1999)